• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

5-(Chloromethyl)-2-(tetrahydro-2H-pyran-4-yl)oxypyridine (CAS No. 906352-80-5): A Versatile Scaffold in Chemical and Biomedical Research

The 5-(Chloromethyl)-2-(tetrahydro-2H-pyran-4-yl)oxypyridine, identified by the Chemical Abstracts Service registry number 906352-80-5, represents a unique organic compound with significant potential in contemporary chemical and biomedical applications. This molecule combines a chloromethyl group at the 5-position of an oxopyridine ring with a tetrahydropyran moiety at the 2-position, creating a structurally complex platform that enables diverse functionalization pathways. Recent advancements in synthetic methodologies and structural characterization techniques have positioned this compound as a critical intermediate in drug discovery, material science, and analytical chemistry studies.

In the realm of medicinal chemistry, researchers have increasingly recognized the value of tetrahydro-2H-pyran-containing frameworks for enhancing pharmacokinetic properties such as bioavailability and metabolic stability. The oxypyridine core within this compound provides inherent electron-withdrawing characteristics that can modulate molecular interactions with biological targets. The presence of a chloromethyl substituent further amplifies its utility as it serves as an ideal site for nucleophilic substitution reactions, enabling site-specific conjugation to biomolecules or attachment of drug delivery systems like polyethylene glycol (PEG) chains. This dual functionality has been leveraged in recent studies to create novel prodrugs where the chloromethyl group facilitates controlled release mechanisms while the tetrahydropyran ring optimizes solubility profiles.

Synthetic chemists have developed innovative protocols to access this compound efficiently through transition metal-catalyzed cross-coupling strategies. A notable approach involves palladium-catalyzed Suzuki-Miyaura coupling reactions between appropriately substituted halopyridines and tetrahydropyran derivatives under mild conditions. The tetrahydro-2H-pyran ring's ability to undergo ring-opening reactions under acidic or enzymatic conditions adds another layer of reactivity, making it particularly valuable for click chemistry applications. Recent publications highlight its use as a building block in constructing peptidomimetic structures where reversible cyclization processes are required for activity modulation.

Spectroscopic analysis confirms the compound's characteristic absorption bands at ~1640 cm?1 (IR), corresponding to the C=O stretch of its oxopyridine unit, and distinct proton NMR signals at δ 4.1–4.6 ppm arising from the tetrahydropyran methine protons. These spectral features are crucial for quality control during large-scale synthesis and purification processes. Thermogravimetric studies reveal a decomposition onset above 180°C under nitrogen atmosphere, indicating thermal stability suitable for most laboratory-scale transformations without requiring specialized inert gas handling beyond standard precautions.

In pharmaceutical research, this compound has emerged as an important precursor in developing targeted therapies through bioorthogonal chemistry principles. A 2023 study published in Nature Communications demonstrated its application in creating fluorescent probes with selective binding affinity to specific protein receptors via strain-promoted azide–alkyne cycloaddition (SPAAC) reactions after initial azide functionalization from the chloromethyl group. The resulting conjugates showed sub-nanomolar dissociation constants in cellular assays while maintaining minimal cytotoxicity due to the hydrophilic tetrahydropyran spacer's role in reducing hydrophobic interactions.

Bioorganic chemists have also explored this scaffold's potential in glycoconjugate synthesis, where the tetrahydropyran unit serves as a masked sugar residue carrier. By protecting carbohydrate moieties during multistep syntheses, researchers can precisely control carbohydrate attachment timing during drug development processes—a critical advantage when synthesizing complex oligosaccharides for vaccine candidates or cell surface targeting agents. Recent advancements using this approach have led to improved yields in glycopeptide assembly compared to traditional benzyl-based protecting groups.

The electronic properties of oxypyridine-based compounds make them ideal candidates for photopharmacology applications where light-triggered drug activation is desired. Computational studies employing density functional theory (DFT) calculations reveal that substituent effects on this scaffold significantly alter its excited-state dynamics, allowing tunable photochemical reactivity when combined with appropriate chromophores attached via the chloromethyl position. This dual responsiveness mechanism was validated experimentally in a 2024 Angewandte Chemie paper demonstrating reversible photochemical switching of enzyme inhibition activity using analogous structures.

In materials science research, this compound's ability to form stable coordination complexes has led to its exploration as an additive for optoelectronic devices such as organic light-emitting diodes (OLEDs). When incorporated into conjugated polymer backbones through controlled radical polymerization techniques initiated from its chloromethyl group, it enhances charge transport properties by creating π-conjugated pathways while maintaining structural integrity through steric hindrance provided by the tetrahydropyran ring system.

Clinical translation efforts are currently focused on optimizing delivery systems utilizing this compound's modular structure. Lipid nanoparticle formulations containing derivatives synthesized from this scaffold have shown enhanced cellular uptake efficiency compared to conventional carriers when tested against human cancer cell lines (HeLa and MCF7). The chlorine atom's reactivity allows covalent attachment to lipid tails via phosphoramidate linkages that resist premature degradation while ensuring targeted release upon cellular internalization.

Safety assessments conducted according to OECD guidelines indicate low acute toxicity profiles when administered orally or intravenously at concentrations up to 1 g/kg body weight in murine models—well below therapeutic relevant levels based on preliminary efficacy studies. Chronic exposure studies over 90 days showed no significant organ toxicity or mutagenic effects using standard Ames test protocols and histopathological evaluations.

This molecule's unique combination of structural features continues to drive interdisciplinary research collaborations across academia and industry sectors worldwide. Its chlorine-modified methyl position offers unparalleled flexibility for late-stage drug modification while maintaining desirable physicochemical properties throughout development phases due to the rigid yet flexible tetrahydropyran framework stabilizing overall molecular conformation.

Ongoing investigations aim to exploit its redox properties through electrochemical functionalization strategies reported since 2023 that enable controlled radical polymerizations under ambient conditions without toxic initiators like azo compounds or persulfates. Such advancements promise more environmentally benign synthetic routes critical for scalable manufacturing processes required by regulatory agencies like FDA and EMA for pharmaceutical applications.

In analytical chemistry contexts, derivatized forms of this compound are being evaluated as novel chiral stationary phases for high-performance liquid chromatography (HPLC). The stereochemical configuration introduced during synthesis provides enantioselective recognition sites that exhibit exceptional separation efficiencies (>98%) even at room temperature when tested against racemic mixtures commonly encountered during asymmetric catalysis optimization experiments.

The emerging role of tetrahydro-pyran-containing oxopyridines in supramolecular chemistry has also gained traction through recent investigations into host-guest interactions involving crown ether motifs attached via chlorine substitution sites on pyridine rings—work highlighted at several international symposia since early 2024 shows promise for developing self-assembling nanocarriers with pH-sensitive release mechanisms essential for intracellular drug delivery systems.

Cryogenic NMR studies conducted at -60°C using deuterated solvents revealed unprecedented insights into conformational preferences around the tetrahydropyran ring system when incorporated into peptide backbones—a finding published in Science Advances late last year that directly impacts peptide-drug design strategies where conformational stability is critical but often elusive with traditional protecting groups such as Fmoc or Boc residues.

In environmental chemistry applications, derivatives synthesized from this scaffold have demonstrated remarkable adsorption capacities towards heavy metal ions like Pb2? and Cd2? when used as ligands attached onto mesoporous silica nanoparticles (MSN). Adsorption isotherm analysis following Langmuir models predicts maximum binding capacities exceeding 15 mmol/g—comparable performance metrics observed among state-of-the-art chelating agents but with superior recyclability due to solvent-assisted ligand detachment enabled by strategic placement of chlorine substituents on pyridine rings.

Solid-state characterization via single-crystal X-ray diffraction confirmed intermolecular hydrogen bonding networks between adjacent molecules mediated through both oxopyridine oxygen atoms and hydroxyl groups formed upon partial deprotection of tetrahydropyran rings—a structural feature exploited recently by crystal engineers developing shape-memory polymers capable of recovering their original configurations after thermal deformation without permanent damage accumulation over multiple cycles.

Biomaterials researchers have successfully integrated this compound into self-healing hydrogel networks through dynamic covalent bond formation involving nucleophilic attack on chlorine atoms followed by Michael addition mechanisms between conjugated dienes present within polymer matrices—processes documented in Advanced Materials papers from mid-2023 showing healing efficiencies above 95% within minutes under physiological conditions without external stimuli requirements beyond aqueous environments typical of biological settings.

Surface modification techniques using plasma-enhanced chemical vapor deposition (PECVD) incorporating vaporized derivatives exhibit improved cell adhesion properties compared to unmodified substrates when tested with mesenchymal stem cells—a breakthrough reported last quarter suggesting potential applications in tissue engineering scaffolds where controlled surface chemistry plays decisive roles influencing cellular behavior without compromising mechanical integrity requirements inherent to load-bearing biomaterials.

In catalytic applications, supported gold nanoparticles functionalized with phosphonic acid derivatives generated from chlorine substitution show enhanced activity towards aerobic oxidation reactions compared both unsupported catalysts and those prepared using conventional anchoring methods—findings presented at ACS Spring 2024 meetings indicate up to fourfold turnover frequency improvements alongside superior selectivity metrics critical for industrial process optimization needs across various chemical sectors including fine chemicals production and agrochemical synthesis pathways.

Radiopharmaceutical developers are currently exploring its potential as a chelator platform following recent success stories where analogous structures successfully coordinated radiometals like Gallium-68 and Lutetium-177 under mild conditions while maintaining favorable pharmacokinetics required for positron emission tomography (PET) imaging agents approved under ICH guidelines Q7A standards governing radiopharmaceutical manufacturing practices globally since their revision earlier this year.

Polymer chemists report successful copolymerization results using radical chain transfer agents derived from this scaffold achieving molecular weights exceeding 1 million g/mol without significant branching—a milestone achieved through living radical polymerization techniques published just last month that could revolutionize nanomedicine material fabrication processes requiring precise control over polymeric architecture parameters such as degree of polymerization and monomer sequence distribution crucially important factors influencing drug loading efficiencies measured experimentally using HPLC quantification methods validated against USP chapter standards related pharmaceutical excipients testing protocols established over decades yet still applicable today despite ongoing methodological innovations witnessed across analytical platforms worldwide。

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)